NSTEMI - Nursing Case Study

Pathophysiology

• Primary mechanism: Rupture of an atherosclerotic plaque in a coronary artery exposes thrombogenic material, leading to the formation of a non-occlusive thrombus that partially obstructs blood flow, causing myocardial ischemia without ST-segment elevation.

• Secondary mechanism: Endothelial dysfunction exacerbates the imbalance between oxygen supply and demand, impairing coronary vasodilation and contributing to ischemic myocardial injury.

• Key complication: Persistent ischemia can lead to myocardial necrosis and subsequent heart failure, increasing the risk for arrhythmias and potentially leading to life-threatening complications.

Patient Profile

Demographics:

68-year-old male, retired construction worker

History:

• Key past medical history: Hypertension, Type 2 Diabetes Mellitus, Chronic Kidney Disease Stage 3, Previous smoker (quit 5 years ago)

• Current medications: Metformin, Lisinopril, Atorvastatin, Aspirin, Furosemide

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Severe chest pain radiating to the left arm

• Key symptoms: Shortness of breath, diaphoresis, nausea, dizziness

• Vital signs: Blood pressure 85/50 mmHg, heart rate 120 bpm, respiratory rate 28 breaths per minute, oxygen saturation 88% on room air, temperature 36.8°C

Section 1

As the emergency department team initiates their assessment of the patient, several critical issues are immediately identified. The patient's altered hemodynamic status is concerning, with systolic hypotension and tachycardia suggesting possible cardiogenic shock secondary to the NSTEMI. His oxygen saturation remains low despite supplemental oxygen, indicative of significant myocardial compromise. Initial laboratory results reveal an elevated troponin level of 0.85 ng/mL, confirming myocardial injury. Furthermore, the patient's renal function is notably impaired, with a serum creatinine level of 2.5 mg/dL, highlighting the risk of acute kidney injury due to both the ongoing ischemia and potential nephrotoxic effects of medications.

Upon further evaluation, the patient demonstrates jugular venous distension, crackles in the lung bases, and peripheral edema, pointing towards developing congestive heart failure. An echocardiogram is performed and reveals a severely reduced ejection fraction of 30%, corroborating the heart’s diminished capacity to maintain adequate circulation. The clinical team notes that the patient's mental status is also declining, with episodes of confusion possibly linked to hypoperfusion and hypoxia.

These findings necessitate immediate interventions to stabilize the patient while considering his complex medical background. The team discusses the initiation of a nitroglycerin infusion to alleviate chest pain and improve coronary perfusion, but they must weigh this against the risk of further exacerbating hypotension. Additionally, the management plan includes cautious fluid resuscitation to support blood pressure while avoiding fluid overload due to compromised cardiac function. The possibility of transferring the patient to the coronary care unit for more intensive monitoring and the initiation of inotropic support is debated, underscoring the critical need for precise clinical judgment in this multifaceted case.

Section 2

As the emergency department team continues to manage the patient, his clinical status undergoes a significant change that requires immediate attention. Despite the initiation of a low-dose nitroglycerin infusion to improve coronary perfusion, the patient's blood pressure remains precariously low, with systolic readings hovering around 85 mmHg. Concurrently, his heart rate accelerates to 130 beats per minute, and his respiratory rate increases to 30 breaths per minute, signaling worsening respiratory distress. The patient's oxygen saturation plummets to 82% even on high-flow oxygen, prompting concern for acute respiratory failure. A repeat chest X-ray reveals worsening pulmonary congestion, indicative of flash pulmonary edema, necessitating urgent intervention to prevent further deterioration.

In response to the escalating situation, the clinical team decides to administer a cautious dose of intravenous furosemide to alleviate pulmonary congestion while closely monitoring the patient's renal function, given his elevated creatinine levels. Additionally, the decision is made to initiate dobutamine infusion to support cardiac output and improve tissue perfusion, balancing the need for inotropic support with the risk of increased myocardial oxygen demand. As these interventions are implemented, the patient's mental status remains a key concern, with persistent confusion and lethargy suggesting ongoing cerebral hypoperfusion.

Despite these efforts, the development of a new complication adds another layer of complexity to the patient's management. A sudden onset of atrial fibrillation with rapid ventricular response is detected on telemetry, further compounding the hemodynamic instability. The team must now deliberate the initiation of rate control with a beta-blocker or calcium channel blocker, carefully considering the potential impact on blood pressure and the patient's already compromised cardiac function. This new arrhythmic challenge necessitates a multidisciplinary approach and highlights the intricate balance required in managing a patient with multifaceted cardiovascular and systemic complications.

Section 3

As the clinical team navigates the patient's complex presentation, they keenly observe his response to the initiated interventions. The administration of intravenous furosemide yields only a marginal improvement in pulmonary congestion, as evidenced by a slight decrease in crackles upon auscultation, but the patient's oxygen saturation stubbornly remains at 84% on high-flow oxygen. The dobutamine infusion, while intended to enhance cardiac output, has inadvertently exacerbated the patient's tachycardia, with his heart rate climbing to 145 beats per minute. This has compounded the challenge of maintaining adequate tissue perfusion without precipitating further myocardial ischemia.

Laboratory assessments reveal a concerning trend: the patient's serum potassium level has plummeted to 2.9 mEq/L, an alarming drop likely precipitated by the diuretic therapy, increasing the risk of potentially life-threatening arrhythmias. Concurrently, his renal function continues to deteriorate, with creatinine levels rising to 2.5 mg/dL, indicating acute kidney injury. The deteriorating renal function and electrolyte imbalance necessitate immediate recalibration of the therapeutic approach, prompting the team to reconsider the diuretic strategy and electrolyte management.

In light of the patient's persistent atrial fibrillation with rapid ventricular response, the team consults cardiology for input on rhythm management. The decision is made to cautiously introduce a low-dose beta-blocker, metoprolol, to achieve rate control while vigilantly monitoring for any adverse hemodynamic impact. The multidisciplinary team, recognizing the criticality of precise electrolyte correction, initiates intravenous potassium supplementation to mitigate the risk of further arrhythmic events. As they navigate these interventions, the team remains acutely aware that the patient’s mental status continues to deteriorate, underscoring the urgency of optimizing cerebral perfusion and electrochemical stability.

Section 4

As the team continues to address the patient's critical condition, they are alerted to a sudden change in his neurological status. The patient, previously responsive and oriented, now exhibits acute confusion and disorientation, raising concerns about compromised cerebral perfusion. Vital signs reveal a further drop in blood pressure to 85/50 mmHg, exacerbating the challenge of maintaining adequate cerebral and systemic perfusion. Despite the initiation of metoprolol for atrial fibrillation rate control, the patient's heart rate remains elevated at 138 beats per minute, complicating the hemodynamic picture.

New diagnostic results from a repeat arterial blood gas analysis indicate a severe metabolic acidosis with a pH of 7.28 and bicarbonate level of 16 mEq/L, suggesting worsening tissue hypoperfusion and possible lactic acidosis. This metabolic disturbance, coupled with the ongoing electrolyte imbalance, necessitates immediate intervention to prevent further deterioration. The team considers initiating a sodium bicarbonate infusion to address the acidosis while carefully evaluating the potential impact on electrolyte dynamics.

In parallel, a stat echocardiogram reveals a significant reduction in left ventricular ejection fraction, now estimated at 25%, highlighting a severe compromise in cardiac function. This finding, in conjunction with the patient's deteriorating renal function and electrolyte imbalances, prompts the team to reevaluate the overall management strategy. Consultation with nephrology and cardiology specialists is urgently sought to devise an integrated approach that addresses the multifaceted challenges of acute kidney injury, electrolyte management, and advanced heart failure, all while striving to stabilize the patient's critical hemodynamic and neurological status.

Section 5

As the medical team grapples with the current challenges, the patient's condition takes another concerning turn. New diagnostic results from a follow-up CT scan of the head, ordered in response to the acute change in neurological status, reveal a small acute ischemic stroke in the left parietal lobe. This finding correlates with the patient's sudden confusion and disorientation, suggesting that the cerebral perfusion issues have led to an embolic event. Further complicating the situation, the patient's blood pressure remains precariously low, now at 82/48 mmHg, despite volume resuscitation efforts. The heart rate continues to be inadequately controlled, fluctuating between 135 and 140 beats per minute, indicating persistent hemodynamic instability.

Concurrently, laboratory results highlight a worsening renal profile, with serum creatinine spiking to 2.8 mg/dL and a drop in urine output to less than 20 mL/hour, indicating acute kidney injury progression. The metabolic acidosis persists, with a repeat arterial blood gas showing minimal improvement: pH 7.30, bicarbonate 17 mEq/L, and lactate levels climbing to 5.4 mmol/L. These findings underscore the critical need for dialysis consideration and reevaluation of the current pharmacologic regimen, particularly in light of the recent stroke diagnosis and ongoing acidosis.

The team is now confronted with the complex interplay of acute heart failure, renal failure, and a new neurological deficit. They must reassess the therapeutic priorities, weighing the benefits of aggressive interventions against the risks of exacerbating the patient's fragile state. The collaboration between cardiology, nephrology, and neurology becomes pivotal as they explore options for mechanical circulatory support, potential anticoagulation modifications given the stroke, and renal replacement therapy initiation. This multidisciplinary approach is crucial in devising a strategic plan aimed at stabilizing the patient while mitigating the risk of further complications.